$ Value
$45K
Shares
16,363
Price
$3
Filed
Jan 30
Insider
Name
GRAYZEL DAVID S.
Title
—
CIK
0001732786
Roles
Transaction Details
Transaction Date
2026-01-15
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
16,363
Footnotes
This option was granted to the Reporting Person, a director of the Issuer pursuant to the 2024 Stock Option and Incentive Plan and pursuant to the Issuer's non-employee director compensation policy. This option shall vest in four equal quarterly installments as of the last date of each calendar quarter subject to the Reporting Person's continued service through such date and represents the Reporting Person's election to receive stock options in lieu of cash retainer fees. Due to administrative oversight this option award initially was not reported. | This option was granted to the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas Venture Life Science Advisors, LLC and as such, the Reporting Person disclaims ownership of such securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
Filing Info
Other Insiders at QTTB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| LAPORTE KATHLEEN | — | — | 2026-01-15 |
|
Morrison Jodie Pope
CEO
|
— | $45K | 2026-02-25 |
|
Kalowski Lee
CFO and President
|
— | $18K | 2026-02-25 |
| Lundberg Sven Ante | — | — | 2026-01-15 |
|
Violette Shelia M.
Chief Scientific Officer
|
— | $13K | 2026-02-25 |